Quadrant Capital Group’s 4D Molecular Therapeutics FDMT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-463	Closed	-$2.58K	–	2775
2024 Q4	$2.58K	Buy	+463	New	+$2.58K	﹤0.01%	2463